MCM
CCEL icon

Maryland Capital Management’s Cryo-Cell International CCEL Stock Holding History

Maryland Capital Management’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$119K Hold
19,563
– – 0.01% 217
2022
Q2 		$115K Hold
19,563
– – 0.01% 223
2022
Q1 		$149K Hold
19,563
– – 0.01% 242
2021
Q4 		$227K Hold
19,563
– – 0.01% 246
2021
Q3 		$237K Buy
+19,563
New +$241K 0.01% 229

Other funds holding CCEL

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
SA
SFI Advisors Montclair, New Jersey $95.2M AUM 23.7% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Maryland Capital Management's CCEL Position: Q3 2022 in Review

Maryland Capital Management held its Cryo-Cell International (CCEL) position steady in Q3 2022 at 19,563 shares worth $119K. The position accounts for 0.01% of the portfolio, ranked #217.

Maryland Capital Management first reported a position in CCEL in Q3 2021 and has held it in 5 quarters since. The position peaked at $237K in Q3 2021. 14 funds tracked by Wall St. Rank hold CCEL as of Q3 2022.

  • Maryland Capital Management held 19,563 shares of Cryo-Cell International worth $119K as of Q3 2022.
  • Maryland Capital Management left its Cryo-Cell International share count unchanged in Q3 2022.
  • Cryo-Cell International made up 0.01% of Maryland Capital Management's portfolio in Q3 2022, its #217 holding.
  • Maryland Capital Management first reported a position in Cryo-Cell International in Q3 2021 and has held it in 5 quarters since.
  • Maryland Capital Management's Cryo-Cell International position peaked at $237K in Q3 2021.
  • 14 funds tracked by Wall St. Rank held Cryo-Cell International as of Q3 2022.

Based on Maryland Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.